Hyperfine Appoints Maria Sainz as President, CEO

Hyperfine has named medical device industry veteran Maria Sainz as its new president and CEO beginning October 24. Interim president CEO Scott Huennekens will remain as executive chair of the board.
 
Sainz held president and CEO positions at AEGEA Medical (bought by CooperSurgical in 2021), Cardiokinetix, and Concentric Medical (bought by Stryker in 2011). She has over 30 years of medical device industry experience and has served on Hyperfine’s board since the company’s Nasdaq listing.
 
“I am excited and honored to lead the next phase of Hyperfine’s growth as we broaden the adoption of Swoop technology, improving access to MR imaging around the world,” Sainz told the press. “With over 90 systems installed globally and our growing value proposition in the ICU and neurocritical care settings, we have established a strong foundation to drive forward commercial momentum. I am eager to join the Hyperfine team as we expand to additional hospitals and continue increasing our clinical applications to improve patient care in mature and emerging healthcare systems.”
 
“We are very pleased to name Ms. Sainz president and CEO of Hyperfine. She carries a successful track record of execution and shareholder value creation across medical device businesses, and her decades of experience are immensely valuable,” said Huennekens. “I am confident in her ability to manage the business with a disciplined approach to spending while leading Hyperfine into its next phase of growth by expanding the Swoop commercial footprint to new sites of care.”
 
“Ms. Sainz has the experience, judgement, and speed needed to ensure that Hyperfine continues to define and own the field of portable MRI. Since inception, Hyperfine has been a technical and AI powerhouse, and now Hyperfine needs to be a commercial force. Ms. Sainz brings the experience, intelligence, and capability to the table to execute that plan,” said Dr. Jonathan Rothberg, Hyperfine’s founder and Vice Chairman.